We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBII
2901
DELISTED
Marrone Bio Innovations, Inc.
MBII
$70K ﹤0.01%
69,630
-649
-0.9% -$787
BXRX
2902
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$70K ﹤0.01%
+7
New +$59.7K
STEX
2903
Streamex Corp
STEX
$81.3M
$69K ﹤0.01%
1,173
+30
+3% +$2.03K
EVFM
2904
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$67K ﹤0.01%
724
+9
+1% +$759
WATT icon
2905
Energous
WATT
$97.6M
$66K ﹤0.01%
62
+4
+7% +$5.95K
MRKR icon
2906
Marker Therapeutics
MRKR
$20.8M
$64K ﹤0.01%
2,213
+39
+2% +$1.42K
SYBX
2907
DELISTED
Synlogic
SYBX
$62K ﹤0.01%
1,600
-25
-2% -$841
CHAP
2908
DELISTED
Chaparral Energy, Inc.
CHAP
$61K ﹤0.01%
34,461
+2,860
+9% +$2.88K
UNT
2909
DELISTED
UNIT Corporation
UNT
$59K ﹤0.01%
85,253
-114,021
-57% -$182K
LQDA icon
2910
Liquidia Corp
LQDA
$7.78B
$58K ﹤0.01%
13,506
+106
+0.8% +$425
LVO icon
2911
LiveOne
LVO
$62.3M
$58K ﹤0.01%
3,736
+64
+2% +$1.1K
LYG icon
2912
Lloyds Banking Group
LYG
$91.2B
$56K ﹤0.01%
16,906
-365
-2% -$1.1K
NL icon
2913
NLI Holdings
NL
$289M
$53K ﹤0.01%
13,550
+145
+1% +$594
PTE
2914
DELISTED
PolarityTE, Inc. Common Stock
PTE
$53K ﹤0.01%
819
-10
-1% -$721
TEUM
2915
DELISTED
Pareteum Corporation
TEUM
$53K ﹤0.01%
121,120
+4,525
+4% +$2.61K
FTSI
2916
DELISTED
FTS International, Inc. Common Stock
FTSI
$51K ﹤0.01%
2,466
+88
+4% +$2.37K
AEG icon
2917
Aegon
AEG
$14B
$50K ﹤0.01%
11,878
-165
-1% -$674
TUSK icon
2918
Mammoth Energy Services
TUSK
$134M
$47K ﹤0.01%
21,166
-7
-0% -$13
IMDX
2919
Insight Molecular Diagnostics
IMDX
$166M
$40K ﹤0.01%
892
– –
METC icon
2920
Ramaco Resources Class A
METC
$627M
$39K ﹤0.01%
11,354
-62
-0.5% -$207
SER icon
2921
Serina Therapeutics
SER
$33.6M
$39K ﹤0.01%
606
-9
-1% -$486
RTW
2922
DELISTED
RTW Retailwinds, Inc.
RTW
$39K ﹤0.01%
48,738
-93
-0.2% -$117
NCSM icon
2923
NCS Multistage Holdings
NCSM
$126M
$38K ﹤0.01%
896
+42
+5% +$1.84K
ALBT
2924
DELISTED
Avalon GloboCare
ALBT
$33K ﹤0.01%
113
+4
+4% +$1K
CHRA
2925
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$33K ﹤0.01%
1,344
+20
+2% +$422
115 116
117
118 119

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.